上肢義肢市場:研發線報告(發展階段、細分市場、地區/國家、監管途徑、主要公司),2024年最新版
市場調查報告書
商品編碼
1543750

上肢義肢市場:研發線報告(發展階段、細分市場、地區/國家、監管途徑、主要公司),2024年最新版

Upper Extremity Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: | 出版商: GlobalData | 英文 108 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

上肢義肢目的是取代部分或完全截肢或先天性缺失的上肢。

本報告調查了上肢義肢市場,並提供了產品概述、開發的產品趨勢、各個開發階段產品的比較分析以及進行的臨床試驗的資訊和最新趨勢。

目錄

第1章 目錄

第2章 簡介

  • 上肢義肢概論

第3章 開發中的產品

  • 上肢義肢- 依開發階段的研發線產品
  • 上肢義肢- 依細分市場的研發線產品
  • 上肢義肢- 依地區的研發線產品
  • 上肢義肢 - 依監管途徑的研發線產品
  • 上肢義肢- 依預計核准日期的研發線產品
  • 上肢義肢-進行的臨床試驗

第4章 上肢義肢-各公司開發的研發線產品

  • 上肢義肢製造商 - 依開發階段的研發線產品
  • 上肢義肢- 依開發階段的研發線產品

第5章 上肢義肢公司及產品概述

第6章 上肢義肢-最新趨勢

第7章 附錄

簡介目錄
Product Code: GDME1791EPD

GlobalData's Medical Devices sector report, "Upper Extremity Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Upper Extremity Prosthetics pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Upper Extremity Prosthetics are designed to replace a partially or fully amputated or congenitally absent upper extremity.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Upper Extremity Prosthetics under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Upper Extremity Prosthetics and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Upper Extremity Prosthetics under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Upper Extremity Prosthetics Overview

3 Products under Development

  • 3.1 Upper Extremity Prosthetics - Pipeline Products by Stage of Development
  • 3.2 Upper Extremity Prosthetics - Pipeline Products by Segment
  • 3.3 Upper Extremity Prosthetics - Pipeline Products by Territory
  • 3.4 Upper Extremity Prosthetics - Pipeline Products by Regulatory Path
  • 3.5 Upper Extremity Prosthetics - Pipeline Products by Estimated Approval Date
  • 3.6 Upper Extremity Prosthetics - Ongoing Clinical Trials

4 Upper Extremity Prosthetics - Pipeline Products under Development by Companies

  • 4.1 Upper Extremity Prosthetics Companies - Pipeline Products by Stage of Development
  • 4.2 Upper Extremity Prosthetics - Pipeline Products by Stage of Development

5 Upper Extremity Prosthetics Companies and Product Overview

6 Upper Extremity Prosthetics- Recent Developments

  • 6.1 Jun 13, 2024: Integrum Signs Memorandum of Understanding with Coapt for the use of its Pattern Recognition Technology with the e-OPRA Implant System
  • 6.2 Oct 12, 2023: Integrum Announces the World's First Long-Term Integrated Bionic Hand Enriched With Motor and Sensory AI

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer